ABT stock: buy or sell?

ABT stock price: $85.71 1.89% At close on November 15th, 2019

Updated on:
November 15th, 2019

5

Shares of Abbott Laboratories rose a beatiful 1.89% and closed at $85.71.

Should I buy ABT stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. That's why is so important to define your own trading strategy that fits your character as inversor. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with Abbott Laboratories stock situation right now, hence this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean ABT will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Abbott Laboratories stock a buy?

Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness. At Stocks2.com, we detected 12 ratings published for ABT stock in the last month.

The general sentiment of these ratings is bullish for ABT stock, with 11 positive ratings.
Is ABT a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-8-14Canaccord GenuityHoldBuy
2019-8-14BMO Capital Marketsn/an/a
2019-7-18Raymond Jamesn/aOutperform
2019-7-18Jefferies Financial Groupn/aBuy
2019-7-18Cowenn/aOutperform
2019-7-18BMO Capital Marketsn/aOutperform
2019-7-16Morgan Stanleyn/aOverweight
2019-6-13Wells Fargo & Con/aOutperform
2019-6-13Bank of American/aBuy
2019-4-15Royal Bank of Canadan/aBuy
2019-3-14Wells Fargo & Con/aBuy
2019-2-7Bank of AmericaBuyBuy

ABT stock analysis

Daily outlook

Shares of Abbott Laboratories rose a beatiful 1.89% and closed at $85.71.

Shares of Abbott Laboratories closed yesterday at $85.71 and rose a beatiful 1.89%. On Oct/9 ABT price bounced up over the SMA of 200 days demonstrating to be a significant support for this stock. From a daily perspective, ABT is in a short term uptrend after plotting its last bottom ($80.90, on November 5th) higher than the previous bottom, and its last top ($84.78, on Tuesday) also over the previous top. Now trading in between its last bottom and last top ABT might consolidate in a plain range, waiting to break out over $84.78 or down under $80.90. On July, ABT hit new all time highs, pushing higher previous ATH of $88.36 recorded on July. New ATHs are usual entry points for many trading setups as there aren't higher resistences.

ABT stock chart (daily)

Weekly outlook

Abbott Laboratories ended this week at $85.71 and escalated a good 2.35%. For 3 weeks in a row, price climbed and marked a profit of 4.90%.

ABT shows a long term strength with several rising tops and rising bottoms. It left a new bottom at $78.20 early October. Previous top ($88.41) will play as a resistance in possible new gains. Far behind is the all-time high Abbott Laboratories hit late July but price is just -3.05% below that top. Since price and SMA20w lines crossed up this week, ABT climbed $1.97 (2.35%).

ABT stock chart (weekly)

ABT stock price history

ABT stock went public on March 17th, 1980 with a price of $0.001. Since then, ABT stock surged a inf%, with a yearly average of inf%. If you had invested $1,000 in ABT stock in 1980, it would worth $inf today.

1: Adjusted price after possible price splits or reverse-splits.

ABT stock historical price chart

ABT stock reached all-time highs on July with a price of $88.41.

ABT stock price target is $90.80

How much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' ABT stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we found 9 price targets for Abbott Laboratories stock:
ABT stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-7-18Raymond JamesRaises Target$87.00$93.006.9%
2019-7-18Jefferies Financial GroupRaises Target$80.00$98.0022.5%
2019-7-18CowenReiterates$86.00$95.0010.5%
2019-7-18BMO Capital MarketsRaises Targetn/a$94.00-
2019-7-16Morgan StanleyRaises Target$85.00$93.009.4%
2019-6-13Wells Fargo & CoRaises Target$89.00$91.002.2%
2019-6-13Bank of AmericaRaises Target$81.00$90.0011.1%
2019-4-15Royal Bank of CanadaRaises Targetn/a$82.00-
2019-2-7Bank of AmericaReiterates$73.00$81.0011%
(in average)$83.00$90.809.0%
The price target for Abbott Laboratories stock is $90.80, moving in a range between $98.00 and $81.00. In average, analysts' outlook on ABT price target is positive, improving the forecast by a 9.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

After presenting its last earnings report on April, Abbott Laboratories . As soon as we get its actual EPS from the earnings report, we will extend this review.
ABT earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q2-n/a0.17n/a
2017-Q32017-10-180.650.661.5%
2017-Q42018-01-240.730.741.4%
2018-Q12018-04-180.580.591.7%
2018-Q22018-07-180.710.732.8%
2018-Q32018-10-170.740.751.4%
2018-Q42019-01-230.810.810.0%
2019-Q12019-04-160.61n/an/a
2019-Q2-n/an/an/a
2019-Q3-n/an/an/a

Annual financial results

Compared to 2017, last anual turnover report draw a brilliant increase of 11.64% to $30,578.00 million USD. When comparing 2018 vs 2017, on the other hand, profit margin (that is, the net income divided by revenues) jumped a 6.00% to 7.74%.

Abbott Laboratories presents anual results in December, and to evaluate its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Abbott Laboratories TTM sales up to March 2019 were $30,723.00 and income $2,622.00 million USD. When comparing this TTM figures with the last reported annuality, we can esteem Abbott Laboratories business evolution since December 2018: Annual turnover up to March, compared to lastest yearly report, stayed steady a neutral 0.47%. Regarding profit margin, Abbott Laboratories remained steady 0.79% to 7.74%

ABT annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$19,660 M-$1,970 M10.0%-
2014$20,247 M2.99%$2,284 M11.3%15.94%
2015$20,405 M0.78%$4,423 M21.7%93.65%
2016$20,853 M2.20%$1,400 M6.7%-68.35%
2017$27,390 M31.35%$477 M1.7%-65.93%
2018$30,578 M11.64%$2,368 M7.7%396.44%
TTM $30,723 M0.47%$2,622 M8.5%10.73%

Quarterly financial results

Abbott Laboratories reported $7,535.00 M in revenues for 2019-Q1, a -2.96% decline compared to previous quarter. Reported quarter earnings marked $672.00 M with a profit margin of 8.92%. Profit margin stayed stable a 0.50% compared to previous quarter when profit margin was 8.42%. When comparing sales to same quarter last year, Abbott Laboratories sales marked a slightly fine growth and appreciated a 1.96%.
ABT quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q2$6,640 M-$269 M4.1%-
2017-Q3$6,830 M2.86%$558 M8.2%107.43%
2017-Q4$7,589 M11.11%$-828 M-10.9%-248.39%
2018-Q1$7,390 M-2.62%$418 M5.7%-150.48%
2018-Q2$7,767 M5.10%$733 M9.4%75.36%
2018-Q3$7,656 M-1.43%$563 M7.4%-23.19%
2018-Q4$7,765 M1.42%$654 M8.4%16.16%
2019-Q1$7,535 M-2.96%$672 M8.9%2.75%

Abbott Laboratories ownership

When you are planning to invest in a stock, it's worth to review its ownership structure.

Abbott Laboratories shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.72% of all shares.

In case of Abbott Laboratories stock, 76.49% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for ABT stock account 0.00%, no big difference from last month.

For a better understanding, the following table shows ownership data compared to other related companies:

ABTBMYBSXHOLXJNJ
Market cap$151.7 B$95.5 B$58.8 B$12.6 B$354.9 B
Total shares1,770.0 M1,630.0 M1,390.0 M267.3 M2,630.0 M
Float shares1,760.0 M1,630.0 M1,390.0 M267.9 M2,630.0 M
  - Institutional holdings (%)76.5%75.0%93.4%99.7%69.2%
  - Insider holdings (%)0.7%0.1%0.2%0.3%0.1%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

ABT summary

Friday, November 15th, 2019
Open$84.67
Close$85.71
Day range$84.40 - $85.71
Previous close$84.12
Session gain1.89%
Average true range$1.18
50d mov avg$82.39
100d mov avg$83.70
200d mov avg$80.43
Daily patternlt06a
Weekly pattern lb03a

Abbott Laboratories performance

To better understand Abbott Laboratories performance you must compare its gains with other related stocks in same sector or industry. For Abbott Laboratories, the comparison is made against Bristol-Myers Squibb, Boston Scientific, Hologic, , Medtronic, Mylan, Pfizer and Thermo Fisher Scientific.
Stock3m6m12m
ABT1.50%13.70%20.96%
BMYBristol-Myers Squ...25.76%27.23%12.09%
BSXBoston Scientific0.38%13.37%13.71%
HOLXHologic-6.56%5.06%11.94%
JNJ3.50%-1.24%-5.02%
MDTMedtronic9.60%29.09%22.22%
MYLMylan-4.48%-9.88%-49.31%
PFEPfizer8.62%-8.38%-11.13%
TMOThermo Fisher Sci...11.18%17.38%27.62%

Abbott Laboratories competitors

We chose a few stocks to conform a list of Abbott Laboratories competitors to watch if you are interested in investing in ABT:

Latest ABT stock news